References UK clinical guidance from the NHS, the British HIV Association (BHIVA), and the British Association for Sexual Health and HIV (BASHH). Last updated: April 2026.
Yes, hepatitis B can be fatal — though this is largely preventable with vaccination, early diagnosis and effective treatment. Most deaths from hepatitis B result from chronic infection that damages the liver over years or decades, leading to cirrhosis or liver cancer. Acute severe hepatitis B can very rarely cause liver failure, but this is uncommon.
Here’s what you need to know.
Order a discreet home STI test
How Hepatitis B Becomes Serious
Most adults who catch hepatitis B clear the infection naturally within 6 months. A small percentage develop chronic infection — long-term persistence of the virus that continues to damage the liver. Over years to decades, chronic hepatitis B can lead to:
| Stage | What Happens |
|---|---|
| Acute infection | Initial illness, usually mild or no symptoms |
| Chronic infection | Long-term virus persistence, often silent |
| Liver fibrosis | Gradual scarring of liver tissue |
| Cirrhosis | Extensive scarring; liver function declines |
| Liver failure | Liver can no longer perform essential functions |
| Liver cancer | Hepatocellular carcinoma, often on a background of cirrhosis |
Who Is at Higher Risk of Chronic Infection?
- Infants infected at birth — up to 90% develop chronic infection
- Young children under 5 — 30-50% become chronic carriers
- Adults with healthy immune systems — under 5% become chronic
- People with HIV or other immune suppression — higher risk
Death from Hepatitis B
Globally, hepatitis B causes hundreds of thousands of deaths per year, mostly from cirrhosis and liver cancer. In the UK, deaths are relatively uncommon thanks to vaccination programmes and access to treatment, but still occur in people with late-diagnosed chronic infection.
How to Prevent Severe Outcomes
Vaccination
The hepatitis B vaccine is highly effective. It’s part of the UK childhood schedule and is recommended for adults at higher risk. Completing the full course gives long-term protection.
Testing
Anyone at risk should be tested. Testing is recommended for:
- People born in high-prevalence countries
- Anyone who has ever injected drugs
- Men who have sex with men
- Sexual partners of hepatitis B carriers
- People with HIV
- Pregnant women (routine NHS screening)
Treatment
Chronic hepatitis B is treated with antiviral drugs that suppress the virus, reduce liver damage and lower the risk of cirrhosis and cancer. Treatment doesn’t usually cure the infection but effectively controls it. Tenofovir and entecavir are the main drugs used.
Monitoring
People with chronic hepatitis B need regular monitoring — blood tests, liver function checks, and often ultrasound to screen for liver cancer. Early detection of complications improves outcomes significantly.
HIV Co-infection
People with both HIV and hepatitis B have faster liver damage progression. Modern HIV treatment includes drugs (tenofovir, emtricitabine, lamivudine) that also treat hepatitis B, making co-infection management more straightforward.
Read more: Hepatitis B and HIV | Hepatitis B treatment | Hepatitis B and C introduction
Frequently Asked Questions
How long does it take hepatitis B to cause serious damage?
Progression from infection to cirrhosis typically takes 20-30 years, though it can be faster with alcohol use or co-infections.
Is hepatitis B worse than hepatitis C?
They have different characteristics. Hepatitis C is more likely to become chronic in adults but is now curable. Hepatitis B is less likely to become chronic but, when it does, often needs lifelong treatment.
Can I prevent hepatitis B death with vaccination?
Yes. Vaccination prevents infection entirely. Completing the full vaccine course gives long-lasting protection and prevents virtually all hepatitis B-related complications.
Related reading
- Blood Test for Syphilis, Hepatitis B and Hepatitis C
- What Is Hepatitis A?
- What Is Hepatitis B?
- Hepatitis B Core Antibody Test Explained
- Hepatitis B Test Kits: What to Know
Sources
- NHS — Sexual health conditions
- BASHH — UK clinical guidelines for STI management
- British HIV Association (BHIVA) — HIV treatment guidelines
- Terrence Higgins Trust — sexual health information
- UK Health Security Agency — STI surveillance data
Steve Page is a recognised expert on Sexually Transmitted Diseases (STDs) and STD treatments, having published numerous articles in peer-reviewed journals and presented his research at conferences around the world. He has an in-depth understanding of the latest medical research on STDs, and is an advocate for the development of new treatments and protocols to improve the health of those affected. In addition to his research, he has dedicated his career to understanding the causes and symptoms of STDs, as well as how to best treat those impacted.
